Nicole Lamanna
5PUBLICATIONS
83CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 09, 2025
Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis.Mazyar Shadman, Jennifer R Brown, Leyla Mohseninejad
|Oct 17, 2024
Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy.Nicole Lamanna, Constantine S Tam, Jennifer A Woyach
|May 16, 2023
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.Michael L Wang, Wojciech Jurczak, Pier Luigi Zinzani
|Apr 16, 2023
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.Prabhjot S Mundi, Filemon S Dela Cruz, Adina Grunn
|Nov 17, 2022
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.Peter Hillmen, Barbara Eichhorst, Jennifer R Brown
Pageof 1
Frequent Collaborators
4 joint publications
Constantine S Tam
2 joint publications
Jennifer R Brown
2 joint publications
Pier Luigi Zinzani
1 joint publications
Peter Hillmen
1 joint publications
Martin Šimkovič
1 joint publications
Alessandra Ferrajoli
1 joint publications
Tadeusz Robak
1 joint publications
Meng Ji
1 joint publications
Prabhjot S Mundi
1 joint publications
Filemon S Dela Cruz
